https://alsnewstoday.com/news/european-approval-amx0035-als-faces-new-hurdle-review/
The CHMP has asked Amylyx Pharmaceuticals to go through a second round of questions as part of the regulatory process for AMX0035 for ALS.
Create an account or login to join the discussion